Adiposogenital dystrophy screening

Revision as of 04:55, 18 August 2021 by Nnabude (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Adiposogenital dystrophy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adiposogenital dystrophy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Head X Ray

CT

MRI

Vision Test

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adiposogenital dystrophy screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adiposogenital dystrophy screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adiposogenital dystrophy screening

CDC on Adiposogenital dystrophy screening

Adiposogenital dystrophy screening in the news

Blogs on Adiposogenital dystrophy screening

Directions to Hospitals Treating Adiposogenital dystrophy

Risk calculators and risk factors for Adiposogenital dystrophy screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ogechukwu Hannah Nnabude, MD

Overview

There is currently no recommended screening for adiposogenital dystrophy

Adiposogenital dystrophy screening

There is currently no recommended screening for adiposogenital dystrophy

References

Template:WH Template:WS